Our data show that increased MET gene copy number is an independent prognostic factor in surgically ESCC, and we firstly find that ESCC might have potentially been up-staged by increased MET gene copy number, which indicates increased MET gene copy number is a very promising parameter, in clinical therapy and follow-up plans. This evidence concerns the gene MET and esophageal squamous cell carcinoma.